Sector ratings Bayer AG

Stocks

Market Closed - Xetra Other stock markets 16:39:26 12/06/2026 BST			5-day change	1st Jan Change
36.19 ^EUR	+1.12%		+0.08%	-2.22%

06-12	Germany's DAX Index Rallies on Inflation Report, US-Iran Deal Hopes	MT
06-12	Berenberg remains cautious on Bayer amid ongoing US litigation

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
BAYER AG	41.16B		AA
ELI LILLY AND COMPANY	1,010B		A
JOHNSON & JOHNSON	580B		BBB
ABBVIE INC.	402B	-	AA	-		-
ROCHE HOLDING AG	330B		AA
NOVARTIS AG	281B		AAA
ASTRAZENECA PLC	280B		A
NOVO NORDISK A/S	197B		A
AMGEN INC.	192B		A
GILEAD SCIENCES, INC.	156B		AA
PFIZER INC.	149B		A
BRISTOL-MYERS SQUIBB COMPANY	117B		A
VERTEX PHARMACEUTICALS INCORPORATED	113B		AA
SANOFI	106B		AA
GSK PLC	106B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	76.54B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.12B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	47.41B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	40.32B		-
Average	216.99B		AA
Weighted average by Cap.			AA